Red Sage Omics · Salvia miltiorrhiza
| Resource | Current status | Portal delivery | Use boundary |
|---|---|---|---|
| Reference genome, GFF, and sequences | Downloadable | FASTA / GFF / ID map | Use the reference version served by this portal. |
| Standard IDs and literature-name mappings | Searchable | Gene Card · Functional Search | Only manually reviewed entries are included; low-confidence mappings are explicitly labeled candidate. |
| Functional annotation and cross-species homologs | Searchable | Annotation · Functional Search | Homology and functional descriptions support annotation and do not replace species-specific validation. |
| Expression summaries and sample metadata | Queryable with result download | Expression Atlas | Cross-study comparisons are bounded by source design, batch effects, and normalization. |
| EMS variants and aggregate-association results | Queryable with result download | EMS Variants | Aggregate association prioritizes candidates and still requires independent genetic and experimental validation. |
| Raw sequencing-data repository deposition | Author deposition pending | Accession and citation details will be added here after deposition. | Current processed portal data are not presented as a substitute for an archival raw-data repository. |
Manually reviewed literature genes related to tanshinones and phenolic acids are available in a searchable topic page with standard IDs, mapping confidence, paper identifiers, and functional summaries. This topic presents traceable high-value candidates and does not claim complete coverage of specialized-metabolism pathways.
KEGG annotation coverage is limited by source databases and cross-species annotation. A gene without a KEGG annotation should not be interpreted as unrelated to a pathway; future releases will continue to add traceable annotations for tanshinone and phenolic-acid biosynthesis.
Subcellular localization, TF-binding sites, and interaction networks are displayed as computational or homology evidence and should be distinguished from experimental results.
Rare EMS variants are aggregated by gene, promoter, or window and assessed by permutation; portal results are not final proof of causal variants.
When using portal results, cite the portal version, query date, source study or database, and the method boundary of the specific module.